Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.79 -0.66 (-1.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Other Non-Current Assets (2010 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Other Non-Current Assets of $6.05 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 347.0% from $1.35 million a year earlier and up 23.8% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Other Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals reported Other Non-Current Assets of $1.39 million, down 69.0% from FY2024.

  • Annual Other Non-Current Assets has a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
  • Across earlier fiscal years, Other Non-Current Assets came in at $4.48 million in FY2024 (+37.5%), $3.26 million in FY2023, $218,000 in FY2022 (-19.9%) and $272,000 in FY2021 (+3.0%).
  • The fiscal Q3 2026 figure is the highest quarterly Other Non-Current Assets since fiscal Q1 2015.
  • On a year-over-year basis, Other Non-Current Assets rose in four of the last seven quarters, with growth averaging 141.3%.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 524.8% in fiscal Q2 2025, against a decline of 69.7% in fiscal Q3 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $4.89 million (Q2 2026), $1.41 million (Q1 2026) and $1.39 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - 6.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.05 Mn
Mar 31, 2026 4.89 Mn
Dec 31, 2025 1.41 Mn
Sep 30, 2025 1.39 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.31 Mn
Dec 31, 2024 3.08 Mn
Sep 30, 2024 4.48 Mn
Jun 30, 2024 4.46 Mn
Mar 31, 2024 210,000.00
Dec 31, 2023 232,000.00
Sep 30, 2023 3.26 Mn
Jun 30, 2023 210,000.00
Mar 31, 2023 210,000.00
Dec 31, 2022 210,000.00
Sep 30, 2022 218,000.00
Jun 30, 2022 275,000.00
Mar 31, 2022 275,000.00
Dec 31, 2021 273,000.00
Sep 30, 2021 272,000.00
API Access

Arrowhead Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ARWR&period=max&api_key=YOUR_API_KEY